Mr. Campbell’s practice focuses on securities, mergers and acquisitions and strategic alliance consulting for high technology companies, venture capital companies and investment banking firms, with a heavy industry focus in life sciences matters. He has represented companies, investors and financial intermediaries in hundreds of equity and debt financing transactions ranging from seed investments in start-up companies to public offerings of equity and debt securities. Mr. Campbell has advised on more than 30 public offerings in his career and dozens of other public capital markets transactions.

Mr. Campbell’s transactional practice has encompassed a large number of merger and acquisition representations, including tender offers, special committee assignments and traditional negotiated transactions. He has represented a leading consumer products company in a wide variety of acquisition, disposition and financing transactions.

Mr. Campbell joined Morrison & Foerster in 1984 and became a partner in 1990. He is co-chair of the firm’s Life Sciences Group. He is listed as recommended by the widely known and respected Chambers Guide to US Lawyers, is listed in Best Lawyers in America (2007) for Corporate Law, and has been recognized since 2003 by his clients and peers as a Northern California “Super Lawyer.”

• Represented Sage, Inc. in its acquisition by Genesis MicroChip and its acquisition of Faroudja Laboratories.
• Represented JDS Uniphase in its acquisitions of Optical Coating Laboratories, Inc., eTek, Inc. and SDL, Inc.
• Represented Cybergold in its acquisition by Mypoints.com.
• Represented Dynavax Technologies Corporation in its $48,127,500 initial public offering of common stock.